Intravenous Iron Drugs Global Market Report 2023: Upsurge in Chronic Renal Disease Bolsters Demand
17 mai 2023 06h28 HE
|
Research and Markets
Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application (Intestinal...
Polydex Pharmaceuticals Issues Third Quarter Financial Results
15 déc. 2022 09h00 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2023, the period ended...
Polydex Pharmaceuticals Issues First Quarter Financial Results
15 juin 2022 08h45 HE
|
Polydex Pharmaceuticals Limited
TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2023, the period ended April...
Outlook on the Intravenous Iron Drugs Global Market to 2028 - Featuring Allergan, AbbVie and American Regent Among Others
15 févr. 2022 08h04 HE
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drugs Market Share, Size, Trends, Industry Analysis Report, By Application, By Products, By Region; Segment Forecast, 2021 - 2028"...
Polydex Pharmaceuticals Issues Third Quarter Financial Results
15 déc. 2021 10h55 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2022, the period ended October...
Global Anemia and Other Blood Disorder Drugs Markets 2020-2030: Focus on Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
25 mars 2021 05h18 HE
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...